International Contact Lens IDefinition Colour Contact Lenses Singapore - English - HSA (Health Sciences Authority)

international contact lens idefinition colour contact lenses

international contact lens pte. ltd. - ophthalmology - intended for the correction of myopia and hyperopia. the lens is intended for single patient use and for daily wear.

NORALIN Noradrenaline (norepinephrine) (as acid tartrate monohydrate) 10 mg/50 mL solution for intravenous infusion, vial Australia - English - Department of Health (Therapeutic Goods Administration)

noralin noradrenaline (norepinephrine) (as acid tartrate monohydrate) 10 mg/50 ml solution for intravenous infusion, vial

boucher & muir pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 20 mg (equivalent: noradrenaline (norepinephrine), qty 10 mg) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sumpathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

NORALIN Noradrenaline (norepinephrine) (as acid tartrate monohydrate) 6 mg/50 mL solution for intravenous infusion, vial Australia - English - Department of Health (Therapeutic Goods Administration)

noralin noradrenaline (norepinephrine) (as acid tartrate monohydrate) 6 mg/50 ml solution for intravenous infusion, vial

boucher & muir pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 12 mg (equivalent: noradrenaline (norepinephrine), qty 6 mg) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sumpathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

NORALIN Noradrenaline (norepinephrine) (as acid tartrate monohydrate) 5 mg/50 mL solution for intravenous infusion, vial Australia - English - Department of Health (Therapeutic Goods Administration)

noralin noradrenaline (norepinephrine) (as acid tartrate monohydrate) 5 mg/50 ml solution for intravenous infusion, vial

boucher & muir pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 10 mg (equivalent: noradrenaline (norepinephrine), qty 5 mg) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sumpathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

NORALIN Noradrenaline (norepinephrine) (as acid tartrate monohydrate) 3 mg/50 mL solution for intravenous infusion, vial Australia - English - Department of Health (Therapeutic Goods Administration)

noralin noradrenaline (norepinephrine) (as acid tartrate monohydrate) 3 mg/50 ml solution for intravenous infusion, vial

boucher & muir pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 6 mg (equivalent: noradrenaline (norepinephrine), qty 3 mg) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

ALBUREX 20 AU Human Albumin 200 g/L (20% w/v) 100 mL solution for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

alburex 20 au human albumin 200 g/l (20% w/v) 100 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 20 g - injection, intravenous infusion - excipient ingredients: sodium octanoate; water for injections; sodium chloride; sodium acetyltryptophanate - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

ALBUREX 20 AU Human Albumin 200 g/L (20% w/v) 50 mL solution for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

alburex 20 au human albumin 200 g/l (20% w/v) 50 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 10 g - injection, intravenous infusion - excipient ingredients: sodium acetyltryptophanate; sodium octanoate; sodium chloride; water for injections - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

ALBUREX 5 AU Human Albumin 50 g/L (5% w/v) 500 mL solution for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

alburex 5 au human albumin 50 g/l (5% w/v) 500 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 25 g - injection, intravenous infusion - excipient ingredients: water for injections; sodium acetyltryptophanate; sodium chloride; sodium octanoate - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

ALBUREX 5 AU Human Albumin 50 g/L (5% w/v) 250 mL solution for intravenous infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

alburex 5 au human albumin 50 g/l (5% w/v) 250 ml solution for intravenous infusion vial

csl behring australia pty ltd - albumin, quantity: 12.5 g - injection, intravenous infusion - excipient ingredients: sodium acetyltryptophanate; sodium octanoate; water for injections; sodium chloride - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient.

BORTEZOMIB EVER PHARMA bortezomib 3.5 mg/1.4 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

bortezomib ever pharma bortezomib 3.5 mg/1.4 ml solution for injection vial

interpharma pty ltd - bortezomib, quantity: 3.5 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections; mannitol - bortezomib ever pharma, in combination with melphalan and prednisone is indicated for the treatment of patients with previously untreated multiple myeloma who are not candidates for high dose chemotherapy. bortezomib ever pharma, as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma. bortezomib ever pharma is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease. bortezomib ever pharma in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma.